TrialThe Lancet. Oncology2017

Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study.

Allen M Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.